Developmental expression of IL-33 in the mouse brain

Area of Science:

• Neuroscience
• Immunology
• Developmental Biology

Background:

• Interleukin-33 (IL-33) is known for its role in inflammatory and autoimmune diseases.
• IL-33 is upregulated in experimental encephalomyelitis models and amplifies innate immune responses in the brain.
• Limited knowledge exists regarding IL-33's function in the normal brain, particularly during development.

Purpose of the Study:

• To investigate the expression pattern of IL-33 in the mouse brain during embryonic and postnatal development.
• To understand the cellular localization and regulation of IL-33 in the developing central nervous system (CNS).

Main Methods:

• Analysis of IL-33 expression in mouse brain tissue across different developmental stages (embryonic to adult).
• Immunohistochemistry and in vitro glial culture techniques to identify IL-33 expressing cells and their localization.
• Assessment of IL-33 expression in astrocytes and oligodendrocyte precursors.

Main Results:

• IL-33 expression was first detected in the CNS during late embryogenesis.
• Expression levels increased from postnatal day 2 (P2) to P9, with highest levels in the cerebellum, pons, thalamus, and olfactory bulbs.
• IL-33 expression declined by P23 and was undetectable in the adult brain. Both astrocytes and oligodendrocyte precursor cells expressed IL-33, predominantly with nuclear staining.

Conclusions:

• IL-33 expression in the normal brain is tightly regulated and transient, occurring during early postnatal development.
• The developmental expression window of IL-33 coincides with critical CNS processes like growth and myelination.
• IL-33 may have functions in the developing CNS independent of inflammatory responses.